Founded in 2009, Shenzhen JYMed Technology Co., Ltd. (abbreviated as JYMed Medicine) is an innovative pharmaceutical company with independent intellectual property rights that integrates the research, development, production and sales of peptide drugs. The company has two wholly-owned subsidiaries, Shenzhen JYMed Technology Co., Ltd. And Hubei JYMed Technology Co., Ltd. The company is the first to establish a research and development technology platform for known products of natural products prodrugs and peptides and protein drug sustained release preparations in China; Most of the products developed are domestic and foreign leading peptide products, and the technology level is at the international advanced and domestic leading position. After the investment of JYMed Medicine by Xingyin Pharmaceutical Group in 2010, JYMed entered a period of rapid development, and the registered capital increased from 2 million to 89.5 million.